These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21808024)

  • 1. Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression.
    Zhang X; Farrell AS; Daniel CJ; Arnold H; Scanlan C; Laraway BJ; Janghorban M; Lum L; Chen D; Troxell M; Sears R
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2790-5. PubMed ID: 21808024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.
    Arnold HK; Zhang X; Daniel CJ; Tibbitts D; Escamilla-Powers J; Farrell A; Tokarz S; Morgan C; Sears RC
    EMBO J; 2009 Mar; 28(5):500-12. PubMed ID: 19131971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.
    Chimge NO; Ahmed-Alnassar S; Frenkel B
    Cell Cycle; 2017 Feb; 16(4):312-318. PubMed ID: 28055379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer.
    Li J; Rodriguez Y; Cheng C; Zeng L; Wong EYM; Xu CY; Zhou MM; Xu PX
    Mol Cell Biol; 2017 Jan; 37(1):. PubMed ID: 27795300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.
    Daniel CJ; Pelz C; Wang X; Munks MW; Ko A; Murugan D; Byers SA; Juarez E; Taylor KL; Fan G; Coussens LM; Link JM; Sears RC
    Mol Cancer Res; 2022 Jul; 20(7):1151-1165. PubMed ID: 35380701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.
    Janghorban M; Farrell AS; Allen-Petersen BL; Pelz C; Daniel CJ; Oddo J; Langer EM; Christensen DJ; Sears RC
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9157-62. PubMed ID: 24927563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.
    Chimge NO; Little GH; Baniwal SK; Adisetiyo H; Xie Y; Zhang T; O'Laughlin A; Liu ZY; Ulrich P; Martin A; Mhawech-Fauceglia P; Ellis MJ; Tripathy D; Groshen S; Liang C; Li Z; Schones DE; Frenkel B
    Nat Commun; 2016 Feb; 7():10751. PubMed ID: 26916619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.
    Wang X; Cunningham M; Zhang X; Tokarz S; Laraway B; Troxell M; Sears RC
    Cancer Res; 2011 Feb; 71(3):925-36. PubMed ID: 21266350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells.
    Chen GS; Chen SY; Liu ST; Hsieh CC; Lee SP; Huang SM
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
    He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
    Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-124-3p.1 promotes cell proliferation through Axin1-dependent Wnt signaling pathway and predicts a poor prognosis of triple-negative breast cancer.
    Yang W; Cui G; Ding M; Yang M; Dai D
    J Clin Lab Anal; 2020 Jul; 34(7):e23266. PubMed ID: 32125723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
    Rodrik V; Gomes E; Hui L; Rockwell P; Foster DA
    FEBS Lett; 2006 Oct; 580(24):5647-52. PubMed ID: 16996503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc.
    Raman D; Chong SJF; Iskandar K; Hirpara JL; Pervaiz S
    Redox Biol; 2020 Jul; 34():101587. PubMed ID: 32512497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC.
    Han X; Ren C; Lu C; Jiang A; Wang X; Liu L; Yu Z
    Oncogene; 2024 Aug; 43(33):2493-2503. PubMed ID: 38969771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation on the c-MYC, AXIN1, and COL11A1 gene expression in colorectal cancer.
    Moradifard S; Minuchehr Z; Ganji SM
    Biotechnol Appl Biochem; 2022 Aug; 69(4):1576-1586. PubMed ID: 34319618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of binding interfaces of the human scaffold protein AXIN1 by peptide microarrays.
    Harnoš J; Ryneš J; Víšková P; Foldynová-Trantírková S; Bajard-Ešner L; Trantírek L; Bryja V
    J Biol Chem; 2018 Oct; 293(42):16337-16347. PubMed ID: 30166345
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
    Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.
    Malempati S; Tibbitts D; Cunningham M; Akkari Y; Olson S; Fan G; Sears RC
    Leukemia; 2006 Sep; 20(9):1572-81. PubMed ID: 16855632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
    Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
    Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.